Soft tissue sarcoma

Last updated: 21 Apr. 2026
Reviewed by: Specialist doctors from the Elfcare quality team

Have you noticed a small lump under your skin that hasn’t gone away? Or perhaps you’ve felt ongoing fatigue, muscle tightness, or swelling in an area you can’t explain. These experiences are common and often harmless, but sometimes they can be your body’s way of asking for attention.

Soft tissue sarcoma is a rare cancer — but its rarity is part of what makes it dangerous. Because it can develop almost anywhere in the body and its early signs are easily mistaken for a muscle strain or benign lump, it is frequently diagnosed late.

MRI is the most important tool for early identification, and Elfcare's full body MRI covers the regions where sarcomas most commonly arise. We believe that understanding your body early is the most powerful step toward lasting wellbeing.

Book your consultation to test your health

What is soft tissue sarcoma?

Soft tissue sarcoma is a rare malignancy that arises from connective tissues like muscle, fat, or nerves. Unlike benign lumps like lipomas, which almost never become cancerous, sarcomas develop directly from malignant cell changes. Because they can appear anywhere, most commonly the limbs or abdomen, and often mimic minor issues like muscle strain, early awareness is essential. Detecting these irregular growths early, before they spread, is critical for effective treatment and long-term recovery.

Symptoms of soft tissue sarcoma

Soft tissue sarcoma is often painless early on, making it easy to dismiss. However, any lump should be evaluated urgently if it is larger than 5 cm, deep within the muscle, growing, or painful at rest.

Common warning signs:

  • A persistent or growing lump or swelling.

  • Localized pain or tenderness as the mass expands.

  • Reduced flexibility or stiffness near joints.

  • Unexplained bruising or a feeling of heaviness in a limb.

Advanced cases may also cause weight loss or persistent fatigue. Because these symptoms often mimic minor injuries, imaging is essential to distinguish a benign mass from a malignancy and protect your long-term health.

Because these symptoms can overlap with more common conditions like inflammation or injury, testing helps provide clarity and direction.

What causes soft tissue sarcoma?

The exact causes of soft tissue sarcoma are not always clear. In most cases, it develops due to changes in how cells grow and divide. However, several factors can increase risk.

Contributing factors include:

  • Genetic predisposition: inherited conditions can impair cellular repair.

  • Radiation exposure: high-dose medical radiation can cause DNA changes decades later.

  • Chemical exposure: long-term contact with dioxins or vinyl chloride increases risk.

  • Lymphoedema: chronic swelling is linked to specific sarcomas like angiosarcoma.

  • Age: risk generally increases after midlife.

While some risks are fixed, tracking biomarkers and monitoring for new growths empowers you to manage your long-term health and catch cellular changes early.

How is soft tissue sarcoma detected?

Soft tissue sarcoma is primarily detected through imaging, with biopsy required for definitive diagnosis. Blood tests have a supportive role, identifying early imbalances that may signal tissue stress or abnormal cell activity.

MRI is the preferred imaging tool because of its superior ability to visualize soft tissues. It defines a mass's size, depth, and relationship to vital structures like nerves and blood vessels, details essential for surgical planning.

Blood tests cannot detect sarcoma directly and are not a screening tool. However, certain markers provide relevant supporting information:

  • CRP (C-reactive protein): monitors systemic inflammation.

  • ALP (alkaline phosphatase): may indicate if a tumor is affecting adjacent bone.

  • Full Blood Count (leukocytes, erythrocytes, haemoglobin, platelets): provides a baseline of overall health (e.g., checking for anemia).

  • Liver Function (ALT/AST): useful if abdominal tumors impact organ function.

MRI identifies suspicious masses and characterizes their features, while blood markers track your body's systemic response. However, tissue analysis (biopsy) remains the only way to confirm a diagnosis and determine the specific subtype.

Why early detection matters

Outcomes for soft tissue sarcoma depend heavily on the stage at discovery. Small, superficial lesions are often dismissed as benign, while deep-seated retroperitoneal tumors frequently go undetected until they are large enough to compress internal organs. This makes early identification a challenge, as many sarcomas do not present symptoms in their initial stages.

Elfcare’s full body MRI addresses this by imaging high-risk regions directly, identifying masses before they become advanced. This proactive approach allows you to seek immediate specialist evaluation while optimizing your nutrition and activity for recovery. By monitoring subtle changes early, you can manage systemic inflammation and feel more empowered in your long-term health.

How Elfcare can help

Elfcare provides a proactive diagnostic strategy by combining precision imaging with deep metabolic insights.

Our full body MRI identifies deep soft tissue masses in the thorax, abdomen, pelvis, and spine-areas where tumors often grow to a significant size before symptoms appear. This is especially vital for detecting retroperitoneal and intra-abdominal tumors that are otherwise impossible to find through a physical exam. For specific areas of concern, targeted regional MRI is also available.

Our 80+ biomarker blood test establishes a comprehensive baseline of your systemic health. By tracking inflammatory markers, liver function, and your full blood count, we create a clinical profile that supports long-term monitoring.

Should any MRI or blood test findings appear suspicious, Elfcare manages the follow-up diagnostics or refers you directly to the appropriate specialist.

Book a consultation to learn more

Summary

Soft tissue sarcomas are rare and often asymptomatic early on, making proactive screening essential for improving long-term outcomes. Elfcare’s full-body MRI serves as the gold standard for identifying these structural abnormalities, while comprehensive blood tests provide vital data on your body’s systemic health and inflammatory response. By establishing a clear baseline and catching subtle changes early, you can protect your mobility and take proactive steps to ensure your long term vitality.

Last updated: 21 Apr. 2026
Reviewed by: Specialist doctors from the quality team at Elfcare

FAQ

  • Soft tissue sarcoma is a rare type of cancer that develops when cells in the body’s connective tissues — such as muscles, fat, nerves, or tendons — begin to grow abnormally. These tissues support and protect the body, and the condition can occur almost anywhere, including the arms, legs, abdomen, or chest. Because it often grows slowly and quietly, it may go unnoticed in its early stages.

  • Early soft tissue sarcoma often causes few or no symptoms and is usually painless at first. Common signs include a lump or swelling that doesn’t go away, increasing discomfort or pressure in one area, stiffness near joints, or a feeling of heaviness or fatigue. Key warning signs requiring urgent evaluation are a lump larger than 5 cm, deep location below the muscle fascia, growth over weeks to months, and pain at rest or at night.

  • In most cases no specific cause is identified. Established risk factors include prior radiation therapy, certain inherited genetic syndromes (Li-Fraumeni, neurofibromatosis type 1), specific chemical exposures (dioxins, vinyl chloride), and chronic lymphoedema. Age is also a factor, with incidence increasing in adults over 50.

  • MRI is the primary imaging tool, providing detailed characterisation of soft tissue masses including size, depth, and relationship to surrounding structures. Biopsy is required for a definitive diagnosis — imaging alone cannot confirm malignancy. Blood tests provide relevant systemic baseline information.

  • Soft tissue sarcoma can only be definitively diagnosed through biopsy, which is performed by a specialist outside of Elfcare. However, our full body MRI can identify suspicious deep soft tissue masses that may not be clinically apparent. If a suspicious finding is made, we take care of further diagnostics or refer you to the appropriate specialist.

  • Yes. Treatment depends on the type, size, and location of the sarcoma, and may include surgery, radiation therapy, chemotherapy, or targeted treatments. When detected early, outcomes improve significantly, and many people respond well to treatment with the right medical support.